Sunshine Heart Inc (SSH) 0.83 $SSH Sunshine Hea
Post# of 273257
Posted On: 09/04/2016 3:11:59 AM
Sunshine Heart Inc (SSH) 0.83 $SSH
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire - Thu Aug 25, 3:30PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on August 18, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved four equity awards, to be effective as of August 22, 2016, under Sunshine Heart's New-Hire Equity Incentive Plan, as material inducements to four individuals entering into employment with the Company. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.
SSH: 0.83 (unch)
Sunshine Heart to Present at the 2016 investMNt Conference on August 24, 2016
GlobeNewswire - Thu Aug 18, 4:30AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer and Chairman of the Board, John Erb, is scheduled to present at the 2016 investMNt Conference in Minneapolis, MN on August 24 at 11:45 AM CT.
SSH: 0.83 (unch)
Sunshine Heart Appoints Megan Brandt as Vice President, Regulatory Affairs and Quality Assurance
GlobeNewswire - Tue Aug 16, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today the appointment of Megan Brandt to the position of Vice President of Regulatory Affairs and Quality Assurance. In this capacity, Ms. Brandt will facilitate and manage quality and regulatory affairs for Sunshine Heart.
SSH: 0.83 (unch)
Sunshine Heart Announces Second Quarter 2016 Financial Results and Provides Company Update
GlobeNewswire - Tue Aug 09, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results for the second quarter ended June 30, 2016. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on the Company's clinical and product development strategy and its recent acquisition of the Aquadex FlexFlow(R) product line.
SSH: 0.83 (unch)
Sunshine Heart Announces Strategic Acquisition of Aquadex Product Line from Baxter and a new credit facility with Silicon Valley Bank
Globe Newswire - Mon Aug 08, 4:30AM CDT
EDEN PRAIRIE, Minn., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced it has acquired the Aquadex product line from an indirect subsidiary of Baxter International Inc. (NYSE:BAX), a global leader in the hospital products and dialysis markets. The Aquadex system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
SSH: 0.83 (unch), BAX: 46.28 (+0.10)
Sunshine Heart to Announce Second Quarter 2016 Results on August 9, 2016
GlobeNewswire - Fri Jul 29, 12:30PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its second quarter 2016 results will be released on Tuesday, August 9, 2016, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.83 (unch)
Sunshine Heart Announces OPTIONS HF Clinical Experience
GlobeNewswire - Tue May 24, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its C-Pulse Heart Assist System was featured in a clinical presentationat the Heart Failure Association of the European Society of Cardiology Meeting, taking place from May 21 to May 24 in Florence, Italy.
SSH: 0.83 (unch)
Sunshine Heart to Release First Quarter 2016 Results on May 3, 2016
GlobeNewswire - Wed Apr 27, 3:15PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its first quarter 2016 results will be released on Tuesday, May 3, 2016, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.83 (unch)
Sunshine Heart awards stock options to Eric Lovett, PhD under NASDAQ Listing Rule 5635(c)(4)
M2 - Wed Jan 20, 7:22AM CST
Medical device company Sunshine Heart (NasdaqCM:SSH) said on Tuesday that board of directors' compensation committee has approved an equity award to Eric Lovett, PhD under its New-Hire Equity Incentive Plan and NASDAQ Listing Rule 5635(c)(4).
SSH: 0.83 (unch)
Sunshine Heart Appoints Eric Lovett as Vice President, Clinical Affairs
GlobeNewswire - Tue Jan 05, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today announced the appointment of Eric Lovett Ph.D., to the position of Vice President, Clinical Affairs. In this capacity, Dr. Lovett will manage the Company's U.S. pivotal study (COUNTER HF(TM)) for its flagship C-Pulse(R) Heart Assist System, a medical device designed to treat patients with moderate to severe heart failure.
SSH: 0.83 (unch)
Sunshine Heart Amends Its Debt Agreement with Silicon Valley Bank
GlobeNewswire - Wed Dec 09, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH) announced today it has amended its debt agreement with Silicon Valley Bank to modify the requirement that the Company raise $20.0 million by March 31, 2016.
SSH: 0.83 (unch), SIVB: 111.68 (+0.69)
Sunshine Heart Announces Departure of Its Chief Executive Officer David A. Rosa
GlobeNewswire - Mon Nov 30, 3:15PM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer, David A. Rosa is leaving the Company, effective November 30, 2015. John L. Erb, Chairman of the Board of Directors of Sunshine Heart, has been named Interim Chief Executive Officer and President and will continue to serve as Chairman of the Board.
SSH: 0.83 (unch)
Sunshine Heart to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015
GlobeNewswire - Wed Nov 25, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Financial Officer, Claudia Drayton, is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference in New York, NY on December 2 at 12:00 PM ET.
SSH: 0.83 (unch)
Sunshine Heart Announces Third Quarter 2015 Results and Provides Corporate Update
GlobeNewswire - Tue Nov 03, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a corporate update for the third quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on its ongoing clinical studies.
SSH: 0.83 (unch)
Sunshine Heart to Release Third Quarter 2015 Results on November 3, 2015
GlobeNewswire - Tue Oct 27, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its third quarter results will be released on Tuesday, November 3, 2015, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.83 (unch)
Sunshine Heart announces inducement stock options to two new hires under NASDAQ Listing Rule 5635(c)(4)
M2 - Fri Oct 09, 6:21AM CDT
Medical device company Sunshine Heart (NasdaqCM:SSH) stated on Thursday that board of directors' compensation committee have approved two equity awards under its new-hire equity incentive plan to two new individuals in accordance with NASDAQ Listing Rule 5635(c)(4).
SSH: 0.83 (unch)
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire - Thu Aug 25, 3:30PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on August 18, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved four equity awards, to be effective as of August 22, 2016, under Sunshine Heart's New-Hire Equity Incentive Plan, as material inducements to four individuals entering into employment with the Company. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan.
SSH: 0.83 (unch)
Sunshine Heart to Present at the 2016 investMNt Conference on August 24, 2016
GlobeNewswire - Thu Aug 18, 4:30AM CDT
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer and Chairman of the Board, John Erb, is scheduled to present at the 2016 investMNt Conference in Minneapolis, MN on August 24 at 11:45 AM CT.
SSH: 0.83 (unch)
Sunshine Heart Appoints Megan Brandt as Vice President, Regulatory Affairs and Quality Assurance
GlobeNewswire - Tue Aug 16, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today the appointment of Megan Brandt to the position of Vice President of Regulatory Affairs and Quality Assurance. In this capacity, Ms. Brandt will facilitate and manage quality and regulatory affairs for Sunshine Heart.
SSH: 0.83 (unch)
Sunshine Heart Announces Second Quarter 2016 Financial Results and Provides Company Update
GlobeNewswire - Tue Aug 09, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results for the second quarter ended June 30, 2016. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on the Company's clinical and product development strategy and its recent acquisition of the Aquadex FlexFlow(R) product line.
SSH: 0.83 (unch)
Sunshine Heart Announces Strategic Acquisition of Aquadex Product Line from Baxter and a new credit facility with Silicon Valley Bank
Globe Newswire - Mon Aug 08, 4:30AM CDT
EDEN PRAIRIE, Minn., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced it has acquired the Aquadex product line from an indirect subsidiary of Baxter International Inc. (NYSE:BAX), a global leader in the hospital products and dialysis markets. The Aquadex system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
SSH: 0.83 (unch), BAX: 46.28 (+0.10)
Sunshine Heart to Announce Second Quarter 2016 Results on August 9, 2016
GlobeNewswire - Fri Jul 29, 12:30PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its second quarter 2016 results will be released on Tuesday, August 9, 2016, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.83 (unch)
Sunshine Heart Announces OPTIONS HF Clinical Experience
GlobeNewswire - Tue May 24, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its C-Pulse Heart Assist System was featured in a clinical presentationat the Heart Failure Association of the European Society of Cardiology Meeting, taking place from May 21 to May 24 in Florence, Italy.
SSH: 0.83 (unch)
Sunshine Heart to Release First Quarter 2016 Results on May 3, 2016
GlobeNewswire - Wed Apr 27, 3:15PM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its first quarter 2016 results will be released on Tuesday, May 3, 2016, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.83 (unch)
Sunshine Heart awards stock options to Eric Lovett, PhD under NASDAQ Listing Rule 5635(c)(4)
M2 - Wed Jan 20, 7:22AM CST
Medical device company Sunshine Heart (NasdaqCM:SSH) said on Tuesday that board of directors' compensation committee has approved an equity award to Eric Lovett, PhD under its New-Hire Equity Incentive Plan and NASDAQ Listing Rule 5635(c)(4).
SSH: 0.83 (unch)
Sunshine Heart Appoints Eric Lovett as Vice President, Clinical Affairs
GlobeNewswire - Tue Jan 05, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) today announced the appointment of Eric Lovett Ph.D., to the position of Vice President, Clinical Affairs. In this capacity, Dr. Lovett will manage the Company's U.S. pivotal study (COUNTER HF(TM)) for its flagship C-Pulse(R) Heart Assist System, a medical device designed to treat patients with moderate to severe heart failure.
SSH: 0.83 (unch)
Sunshine Heart Amends Its Debt Agreement with Silicon Valley Bank
GlobeNewswire - Wed Dec 09, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH) announced today it has amended its debt agreement with Silicon Valley Bank to modify the requirement that the Company raise $20.0 million by March 31, 2016.
SSH: 0.83 (unch), SIVB: 111.68 (+0.69)
Sunshine Heart Announces Departure of Its Chief Executive Officer David A. Rosa
GlobeNewswire - Mon Nov 30, 3:15PM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer, David A. Rosa is leaving the Company, effective November 30, 2015. John L. Erb, Chairman of the Board of Directors of Sunshine Heart, has been named Interim Chief Executive Officer and President and will continue to serve as Chairman of the Board.
SSH: 0.83 (unch)
Sunshine Heart to Present at the 27th Annual Piper Jaffray Healthcare Conference on December 2, 2015
GlobeNewswire - Wed Nov 25, 4:30AM CST
Sunshine Heart, Inc. (Nasdaq:SSH) announced today that Chief Financial Officer, Claudia Drayton, is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference in New York, NY on December 2 at 12:00 PM ET.
SSH: 0.83 (unch)
Sunshine Heart Announces Third Quarter 2015 Results and Provides Corporate Update
GlobeNewswire - Tue Nov 03, 4:30AM CST
Sunshine Heart, Inc. (NASDAQ:SSH) announced today its financial results and provided a corporate update for the third quarter of 2015. The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on its ongoing clinical studies.
SSH: 0.83 (unch)
Sunshine Heart to Release Third Quarter 2015 Results on November 3, 2015
GlobeNewswire - Tue Oct 27, 4:30AM CDT
Sunshine Heart, Inc. (NASDAQ:SSH) today announced that its third quarter results will be released on Tuesday, November 3, 2015, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
SSH: 0.83 (unch)
Sunshine Heart announces inducement stock options to two new hires under NASDAQ Listing Rule 5635(c)(4)
M2 - Fri Oct 09, 6:21AM CDT
Medical device company Sunshine Heart (NasdaqCM:SSH) stated on Thursday that board of directors' compensation committee have approved two equity awards under its new-hire equity incentive plan to two new individuals in accordance with NASDAQ Listing Rule 5635(c)(4).
SSH: 0.83 (unch)
(0)
(0)Scroll down for more posts ▼